Vergoeding 2019-2023 voor ATC-subgroep N06AA : Niet-selectieve monoamine-heropnameremmers
- Raming voor de totale Zvw-populatie
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| N06AA02 Imipramine | 141.350 | 159.910 | 404.590 | 686.300 | 630.900 |
| N06AA04 Clomipramine | 1.158.700 | 1.151.800 | 1.138.500 | 1.221.900 | 1.200.300 |
| N06AA09 Amitriptyline | 2.803.100 | 2.965.900 | 2.817.200 | 2.948.100 | 2.875.400 |
| N06AA10 Nortriptyline (Nortrilen ®) | 3.796.500 | 3.548.900 | 3.643.600 | 3.949.800 | 4.233.800 |
| N06AA12 Doxepine | 82.811 | 20.838 | 274 | 48 | 14 |
| N06AA16 Dosulepine (Prothiaden ®) | 45.837 | 53.374 | 55.440 | 52.979 | 49.932 |
| N06AA21 Maprotiline | 50.288 | 64.993 | 66.575 | 41.164 | 36.528 |
| Totaal | 8.078.586 | 7.965.715 | 8.126.179 | 8.900.291 | 9.026.874 |